---
title: "Heron Therapeutics to report Q2 results, host conference call and webcast"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293932913.md"
description: "Heron Therapeutics will report its Q2 results and host a conference call and live webcast on August 10, 2026, at 8:30 a.m. ET."
datetime: "2026-07-27T12:31:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293932913.md)
  - [en](https://longbridge.com/en/news/293932913.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293932913.md)
generator: "portal-rs"
---

# Heron Therapeutics to report Q2 results, host conference call and webcast

-   Heron Therapeutics schedules a conference call, live webcast on Aug. 10, 2026 at 8:30 a.m. ET to report Q2 results. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heron Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607270830PRIMZONEFULLFEED9767924) on July 27, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [HRTX.US](https://longbridge.com/en/quote/HRTX.US.md)

## Related News & Research

- [Itera ASA to present preliminary Q2 2026 results via webcast](https://longbridge.com/en/news/296590225.md)
- [MasterCraft Boat Holdings to webcast fiscal Q4 and full-year earnings call](https://longbridge.com/en/news/296784363.md)
- [Sildarvinnslan schedules investor webcast to present Q2 2026 results](https://longbridge.com/en/news/297017418.md)
- [Ten Holdings announces first annual stockholder meeting via webcast](https://longbridge.com/en/news/297014141.md)
- [Frontline schedules Q2 2026 results webcast and conference call](https://longbridge.com/en/news/296622834.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**